Reply to K.I. Pritchard.

Authors :: Fontein DB
van de Velde CJ
Source :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2013 Dec 10; Vol. 31 (35), pp. 4477-9. Date of Electronic Publication: 2013 Nov 04.
Publication Year :: 2013

Subjects :: Antineoplastic Agents, Hormonal adverse effects
Antineoplastic Agents, Hormonal therapeutic use
Aromatase Inhibitors therapeutic use
Breast Neoplasms pathology
Disease-Free Survival
Female
Genital Diseases, Female chemically induced
Humans
Kaplan-Meier Estimate
Musculoskeletal Diseases chemically induced
Outcome Assessment, Health Care methods
Outcome Assessment, Health Care statistics & numerical data
Proportional Hazards Models
Tamoxifen therapeutic use
Vasomotor System drug effects
Vasomotor System pathology
Aromatase Inhibitors adverse effects
Breast Neoplasms drug therapy
Tamoxifen adverse effects

Language :: English
ISSN :: 1527-7755
Volume :: 31
Issue :: 35
Database :: MEDLINE
Journal :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Type :: Editorial & Opinion
Accession number :: 24190123
Full Text :: https://doi.org/10.1200/JCO.2013.53.1707